MS Drug Ampyra Gets FDA Nod

Ampyra Improves Walking in Many Multiple Sclerosis Patients

Jan. 22, 2010 - The FDA has approved Ampyra (dalfampridine), which improves walking ability in adults with multiple sclerosis (MS). ...Read the full report in WebMD